CIMT 2018 Annual Meeting

CIMT 2018 Annual Meeting, Mainz, 15-17 May 2018

ORYX presented positive clinical data for oncolytic parvovirus ParvOryx in combination with immune modulators in recurrent glioblastoma at the CIMT Annual Meeting that took place in Mainz, Germany on May 15-17, 2018.